Announcements Trials
Browse Landscape

Phase

Phase 1/2 5Phase 1 5Phase NA 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 458Lymphoid 57Other hematologic neoplasm 35Sarcoma 12Tumor-Agnostic 11Gynecologic 8Breast 6Other solid neoplasm 5Head & Neck 4CNS 4Myeloid 3Classical hematology 3Plasma cell 2Genitourinary 2Endocrine 2Thoracic 1Other 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1Lymphoma 1

Interventions

Nivolumab 114Ipilimumab 114pembrolizumab 108aldesleukin 76Cyclophosphamide 70fludarabine phosphate 51Interleukin-2 48Temozolomide 41Dacarbazine 36trametinib 33dabrafenib 30Bevacizumab 30sargramostim 29Radiotherapy 29incomplete Freund's adjuvant 27fludarabine 27Vemurafenib 25Radiosurgery 25Carboplatin 25Paclitaxel 23binimetinib 22Biopsy 22CTLA-4 Antigen 21Peripheral Blood Stem Cell Transplantation 20encorafenib 19cemiplimab 19atezolizumab 19HhAntag691 19Mycophenolic Acid 18Aminolevulinic Acid 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leucovorin × Dermatologic × Clear all
NCT00002557 2013-12-18

Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides

National Cancer Institute (NCI)

Phase 2 Unknown
3 enrolled
DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡